Showing results (1031-1040 of 1,702) with videos related to
Sort By:
Pageof 171
Social Science & Medicine (1982)|May 11, 2025
Considerations for the epidemiological evaluation of hyperlocal interventions: A case study of the New York City overdose prevention centersBennett Allen, Brandi Moore, Victoria A Jent, et al.Nanoscale|November 7, 2017
Determining molecular orientation via single molecule SERS in a plasmonic nano-gapAddison R L Marshall, Jamie Stokes, Francesco N Viscomi, et al.Chest|November 12, 2002
Oximeter performance: the influence of acquisition parametersDavid G Davila, Kathy C Richards, Buddy L Marshall, et al.Implementation Science Communications|August 31, 2025
Integrating HIV prevention services into care settings for people with opioid use disorder (OUD): a study protocol for implementation strategy development and modelingMofan Gu, Ruben G Martinez, Hannah Parent, et al.ACS Biomaterials Science & Engineering|November 29, 2021
Three-Dimensional-Printed Flexible Scaffolds Have Tunable Biomimetic Mechanical Properties for Intervertebral Disc Tissue EngineeringSamantha L Marshall, Timothy D Jacobsen, Erik Emsbo, et al.Substance Use & Misuse|May 12, 2023
Receipt of Prescription Psychostimulants and Stimulant-Involved Fatal Overdose: A Population-Based Case-Control StudyAlexandria Macmadu, Alexandra J Banks, Benjamin D Hallowell, et al.Journal of Substance Use and Addiction Treatment|December 19, 2023
Association between comorbid chronic pain or prior hospitalization for mental illness and substance use treatment among a cohort at high risk of opioid overdoseMaayan N Rosenfield, Francesca L Beaudoin, Rachel Gaither, et al.American Journal of Surgery|November 9, 2010
Ethnic disparities are reduced in VA colon cancer patientsCelia N Robinson, Courtney J Balentine, Christy L Marshall, et al.Epidemiology (Cambridge, Mass.)|June 18, 2019
Increased Risk of Opioid Overdose Death Following Cold Weather: A Case-Crossover StudyWilliam C Goedel, Brandon D L Marshall, Keith R Spangler, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignanciesJ A Posey, R Raspet, U Verma, et al.Pageof 171